Additional file 1.

Peroxiredoxin 4 in clinical indications. This overview does not presume to be complete. Indeed, cited cancer settings are limited to subgroups with important clinical findings beyond changes in peroxiredoxin 4 expression. Unless otherwise mentioned, the term 'Prx4' refers to intracellular protein levels.

Format: DOC Size: 62KB Download file

This file can be viewed with: Microsoft Word Viewer

Schulte BMC Medicine 2011 9:137   doi:10.1186/1741-7015-9-137